Loading profile…
Riskpilot
← Back to search
Sign in
Get full access
JA
Johan Axel Living
Chief Executive Officer, Lipigon Pharmaceuticals AB
Färgargårdstorget 44 Lgh 1502
SE
5 active roles
Watchlist
Share
Overview
Companies & roles
Network
Active roles
5
directorships & management
Past roles
0
historical positions
Dissolved companies
0
in directorship history
Career timeline
2025 – now
Chief Executive Officer, Lipigon Pharmaceuticals AB
2024 – now
Chief Executive Officer, PROSMEDIC SWEDEN AB
2024 – now
Board of Directors, Living Consulting AB
2022 – now
Owner, G&U Living Handelsbolag
2020 – now
Chief Executive Officer, XNK Therapeutics AB
Personal details
Nationality
SE
Address
Färgargårdstorget 44 Lgh 1502
Active roles
5 positions
Company
Role
Period
Ownership
Status
Lipigon Pharmaceuticals AB
CVR 5568109077
Management
Chief Executive Officer
Since 2025
—
Active
XNK Therapeutics AB
CVR 5568946601
Management
Chief Executive Officer
Since 2020
—
Dissolved
PROSMEDIC SWEDEN AB
CVR 5569615635
Management
Chief Executive Officer
Since 2024
—
Active
Living Consulting AB
CVR 5594960147
Board
Board of Directors
Since 2024
—
Active
G&U Living Handelsbolag
CVR 9697054220
Owner
Owner
Since 2022
—
Active
Co-directors & shared companies
Person
Role
Shared companies
Profile
HE
Hans Erik Andreas Vretblom
Chief Auditor
1
company
View profile
SK
Stefan Kristoffer Nilsson
Chief Executive Officer
1
company
View profile
ND
Nils David Westberg
Board of Directors
1
company
View profile
JE
Jens Eric Ålander
Board of Directors
1
company
View profile
OF
Olof Fredrik Lindgren
Board of Directors
1
company
View profile
Company network
Active roles
Johan Axel Living
Lipigon Pharmaceuticals AB
Chief Executive Officer
XNK Therapeutics AB
Chief Executive Officer
PROSMEDIC SWEDEN AB
Chief Executive Officer
Living Consulting AB
Board of Directors
G&U Living Handelsbolag
Owner